Molecular epidemiology of Usher syndrome in Italy

Diego Vozzi, Anu Aaspõllu, Emmanouil Athanasakis, Anna Berto, Antonella Fabretto, Danilo Licastro, Maigi Külm, Francesco Testa, Patrizia Trevisi, Marju Vahter, Carmela Ziviello, Alessandro Martini, Francesca Simonelli, Sandro Banfi, Paolo Gasparini

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Purpose: Usher syndrome is an autosomal recessive disorder characterized by hearing and vision loss. Usher syndrome is divided into three clinical subclasses (type 1, type 2, and type 3), which differ in terms of the severity and progression of hearing loss and the presence or absence of vestibular symptoms. Usher syndrome is defined by significant genetic heterogeneity, with at least 12 distinct loci described and 9 genes identified. This study aims to provide a molecular epidemiology report of Usher syndrome in Italy. Methods: Molecular data have been obtained on 75 unrelated Italian patients using the most up-to date technology available for the screening of Usher syndrome gene mutations, i.e., the genotyping microarray developed by Asper Biotech (Tartu, Estonia), which simultaneously investigates 612 different marker positions using the well established arrayed primer extension methodology (APEX). Results: Using this method, we found that 12% of cases (9 out of 75) harbored homozygous or compound heterozygous mutations in the gene positions analyzed, whereas 20% (15 out of 75) of the patients were characterized by the presence of only one mutated allele based on the positions analyzed. One patient was found to be compound heterozygous for mutations in two different genes and this represents an example of possible digenic inheritance in Usher syndrome. A total of 66.6% of cases (50 out of 75) were found to be completely negative for the presence of Usher syndrome gene mutations in the detected positions. Mutations detected by the array were confirmed by direct sequencing. Conclusions: These findings highlight the efficacy of the APEX-based genotyping approach in the molecular assessment of Usher patients, suggesting the presence of alleles not yet identified and/or the involvement of additional putative genes that may account for the pathogenesis of Usher syndrome.

Original languageEnglish
Pages (from-to)1662-1668
Number of pages7
JournalMolecular Vision
Volume17
Publication statusPublished - 2011
Externally publishedYes

Fingerprint

Usher Syndromes
Molecular Epidemiology
Italy
Mutation
Genes
Deaf-Blind Disorders
Alleles
Estonia
Gene Order
Genetic Heterogeneity
Hearing Loss
Technology

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Vozzi, D., Aaspõllu, A., Athanasakis, E., Berto, A., Fabretto, A., Licastro, D., ... Gasparini, P. (2011). Molecular epidemiology of Usher syndrome in Italy. Molecular Vision, 17, 1662-1668.

Molecular epidemiology of Usher syndrome in Italy. / Vozzi, Diego; Aaspõllu, Anu; Athanasakis, Emmanouil; Berto, Anna; Fabretto, Antonella; Licastro, Danilo; Külm, Maigi; Testa, Francesco; Trevisi, Patrizia; Vahter, Marju; Ziviello, Carmela; Martini, Alessandro; Simonelli, Francesca; Banfi, Sandro; Gasparini, Paolo.

In: Molecular Vision, Vol. 17, 2011, p. 1662-1668.

Research output: Contribution to journalArticle

Vozzi, D, Aaspõllu, A, Athanasakis, E, Berto, A, Fabretto, A, Licastro, D, Külm, M, Testa, F, Trevisi, P, Vahter, M, Ziviello, C, Martini, A, Simonelli, F, Banfi, S & Gasparini, P 2011, 'Molecular epidemiology of Usher syndrome in Italy', Molecular Vision, vol. 17, pp. 1662-1668.
Vozzi D, Aaspõllu A, Athanasakis E, Berto A, Fabretto A, Licastro D et al. Molecular epidemiology of Usher syndrome in Italy. Molecular Vision. 2011;17:1662-1668.
Vozzi, Diego ; Aaspõllu, Anu ; Athanasakis, Emmanouil ; Berto, Anna ; Fabretto, Antonella ; Licastro, Danilo ; Külm, Maigi ; Testa, Francesco ; Trevisi, Patrizia ; Vahter, Marju ; Ziviello, Carmela ; Martini, Alessandro ; Simonelli, Francesca ; Banfi, Sandro ; Gasparini, Paolo. / Molecular epidemiology of Usher syndrome in Italy. In: Molecular Vision. 2011 ; Vol. 17. pp. 1662-1668.
@article{d3964f20512e456f9887c23fc141474f,
title = "Molecular epidemiology of Usher syndrome in Italy",
abstract = "Purpose: Usher syndrome is an autosomal recessive disorder characterized by hearing and vision loss. Usher syndrome is divided into three clinical subclasses (type 1, type 2, and type 3), which differ in terms of the severity and progression of hearing loss and the presence or absence of vestibular symptoms. Usher syndrome is defined by significant genetic heterogeneity, with at least 12 distinct loci described and 9 genes identified. This study aims to provide a molecular epidemiology report of Usher syndrome in Italy. Methods: Molecular data have been obtained on 75 unrelated Italian patients using the most up-to date technology available for the screening of Usher syndrome gene mutations, i.e., the genotyping microarray developed by Asper Biotech (Tartu, Estonia), which simultaneously investigates 612 different marker positions using the well established arrayed primer extension methodology (APEX). Results: Using this method, we found that 12{\%} of cases (9 out of 75) harbored homozygous or compound heterozygous mutations in the gene positions analyzed, whereas 20{\%} (15 out of 75) of the patients were characterized by the presence of only one mutated allele based on the positions analyzed. One patient was found to be compound heterozygous for mutations in two different genes and this represents an example of possible digenic inheritance in Usher syndrome. A total of 66.6{\%} of cases (50 out of 75) were found to be completely negative for the presence of Usher syndrome gene mutations in the detected positions. Mutations detected by the array were confirmed by direct sequencing. Conclusions: These findings highlight the efficacy of the APEX-based genotyping approach in the molecular assessment of Usher patients, suggesting the presence of alleles not yet identified and/or the involvement of additional putative genes that may account for the pathogenesis of Usher syndrome.",
author = "Diego Vozzi and Anu Aasp{\~o}llu and Emmanouil Athanasakis and Anna Berto and Antonella Fabretto and Danilo Licastro and Maigi K{\"u}lm and Francesco Testa and Patrizia Trevisi and Marju Vahter and Carmela Ziviello and Alessandro Martini and Francesca Simonelli and Sandro Banfi and Paolo Gasparini",
year = "2011",
language = "English",
volume = "17",
pages = "1662--1668",
journal = "Molecular Vision",
issn = "1090-0535",

}

TY - JOUR

T1 - Molecular epidemiology of Usher syndrome in Italy

AU - Vozzi, Diego

AU - Aaspõllu, Anu

AU - Athanasakis, Emmanouil

AU - Berto, Anna

AU - Fabretto, Antonella

AU - Licastro, Danilo

AU - Külm, Maigi

AU - Testa, Francesco

AU - Trevisi, Patrizia

AU - Vahter, Marju

AU - Ziviello, Carmela

AU - Martini, Alessandro

AU - Simonelli, Francesca

AU - Banfi, Sandro

AU - Gasparini, Paolo

PY - 2011

Y1 - 2011

N2 - Purpose: Usher syndrome is an autosomal recessive disorder characterized by hearing and vision loss. Usher syndrome is divided into three clinical subclasses (type 1, type 2, and type 3), which differ in terms of the severity and progression of hearing loss and the presence or absence of vestibular symptoms. Usher syndrome is defined by significant genetic heterogeneity, with at least 12 distinct loci described and 9 genes identified. This study aims to provide a molecular epidemiology report of Usher syndrome in Italy. Methods: Molecular data have been obtained on 75 unrelated Italian patients using the most up-to date technology available for the screening of Usher syndrome gene mutations, i.e., the genotyping microarray developed by Asper Biotech (Tartu, Estonia), which simultaneously investigates 612 different marker positions using the well established arrayed primer extension methodology (APEX). Results: Using this method, we found that 12% of cases (9 out of 75) harbored homozygous or compound heterozygous mutations in the gene positions analyzed, whereas 20% (15 out of 75) of the patients were characterized by the presence of only one mutated allele based on the positions analyzed. One patient was found to be compound heterozygous for mutations in two different genes and this represents an example of possible digenic inheritance in Usher syndrome. A total of 66.6% of cases (50 out of 75) were found to be completely negative for the presence of Usher syndrome gene mutations in the detected positions. Mutations detected by the array were confirmed by direct sequencing. Conclusions: These findings highlight the efficacy of the APEX-based genotyping approach in the molecular assessment of Usher patients, suggesting the presence of alleles not yet identified and/or the involvement of additional putative genes that may account for the pathogenesis of Usher syndrome.

AB - Purpose: Usher syndrome is an autosomal recessive disorder characterized by hearing and vision loss. Usher syndrome is divided into three clinical subclasses (type 1, type 2, and type 3), which differ in terms of the severity and progression of hearing loss and the presence or absence of vestibular symptoms. Usher syndrome is defined by significant genetic heterogeneity, with at least 12 distinct loci described and 9 genes identified. This study aims to provide a molecular epidemiology report of Usher syndrome in Italy. Methods: Molecular data have been obtained on 75 unrelated Italian patients using the most up-to date technology available for the screening of Usher syndrome gene mutations, i.e., the genotyping microarray developed by Asper Biotech (Tartu, Estonia), which simultaneously investigates 612 different marker positions using the well established arrayed primer extension methodology (APEX). Results: Using this method, we found that 12% of cases (9 out of 75) harbored homozygous or compound heterozygous mutations in the gene positions analyzed, whereas 20% (15 out of 75) of the patients were characterized by the presence of only one mutated allele based on the positions analyzed. One patient was found to be compound heterozygous for mutations in two different genes and this represents an example of possible digenic inheritance in Usher syndrome. A total of 66.6% of cases (50 out of 75) were found to be completely negative for the presence of Usher syndrome gene mutations in the detected positions. Mutations detected by the array were confirmed by direct sequencing. Conclusions: These findings highlight the efficacy of the APEX-based genotyping approach in the molecular assessment of Usher patients, suggesting the presence of alleles not yet identified and/or the involvement of additional putative genes that may account for the pathogenesis of Usher syndrome.

UR - http://www.scopus.com/inward/record.url?scp=79960011547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960011547&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 1662

EP - 1668

JO - Molecular Vision

JF - Molecular Vision

SN - 1090-0535

ER -